Literature DB >> 16106111

Factors influencing length of hospital stay in patients with bacterial pleural effusion.

T Soriano1, J Alegre, C Alemán, E Ruiz, A Vázquez, J L Carrasco, R Segura, A Ferrer, T Fernández de Sevilla.   

Abstract

BACKGROUND: Factors influencing length of hospital stay have been poorly analyzed in parapneumonic pleural effusions (PPE).
OBJECTIVES: The aim of this work is to identify the variables that determine increased hospital stay in patients with infectious pleural effusion (PE). PATIENTS AND METHODS: We analyzed 112 patients with PE: empyema, complicated parapneumonic and non-complicated parapneumonic. Epidemiologic, biochemical, therapeutic and radiological variables were analyzed. Correlations with hospital stay were studied using the Student's t test, analysis of variance, Mann-Whitney U-test and linear regression model.
RESULTS: Among the 112 patients studied, there were 32 empyema, 50 complicated and 30 non-complicated parapneumonic cases. The median of length stay for all patients was 17 days. Longer hospitalization was required in patients with empyemic PE (p = 0.015), patients with underlying diseases (p = 0.003), those needing pleural drainage (p = 0.005) or decortication (p = 0.043) and those presenting unfavorable radiological outcome after treatment (p = 0.02). Biochemical parameters associated with longer hospital stay were elevated pleural fluid polymorphonuclear elastase (p = 0.001, r = 0.307) and lactate dehydrogenase (p = 0.001, r = 0.312). After linear regression analysis, only underlying disease, pleural drainage and pleural fluid polymorphonuclear elastase values remained in the model, explaining 23.1% of the variability of days of hospitalization.
CONCLUSIONS: The patients with PPE and empyema who required longer hospitalization were those with purulent fluid, underlying disease, surgical drainage and/or decortication, with unfavorable radiological outcome and higher pleural fluid levels of lactate dehydrogenase and polymorphonuclear elastase. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106111     DOI: 10.1159/000087366

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

1.  Change in Pulmonary Function Following Decortication for Chronic Pleural Empyema.

Authors:  Sujith Varghese Abraham; Prashant Chikkahonnaiah
Journal:  Turk Thorac J       Date:  2020-01-01

2.  Comparison of outcomes between primary and secondary lung decortication.

Authors:  Joseph Motshedi Sekgololo; Risenga Frank Chauke
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

3.  A systematic review of comorbidities and outcomes of adult patients with pleural infection.

Authors:  Tamsin N Cargill; Maged Hassan; John P Corcoran; Elinor Harriss; Rachelle Asciak; Rachel M Mercer; David J McCracken; Eihab O Bedawi; Najib M Rahman
Journal:  Eur Respir J       Date:  2019-10-01       Impact factor: 16.671

4.  Open thoracotomy and decortication for chronic empyema.

Authors:  Rafael Andrade-Alegre; Juan D Garisto; Salomón Zebede
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

5.  Surgical management of stage III pediatric empyema thoracis.

Authors:  Aditya Pratap Singh; Arvind Kumar Shukla; Pramila Sharma; Jyotsna Shukla
Journal:  Lung India       Date:  2018 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.